2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
20
Stomach Neoplasms
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma
6
Neoplasms, Plasma Cell
4
Recurrence
3
Dyspepsia
3
Peptic Ulcer
2
Gastritis
2
Skin Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Persistence of Infection With Helicobacter Pylori
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Infections
1
Helicobacter Infections
1
Familial primary gastric lymphoma
1
Drug-Related Side Effects and Adverse Reactions
1
Chemotherapy Effect
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
B-cell Malignancies
1
Atrophy
1
Interventions
Cyclophosphamide
18
ofatumumab
14
fludarabine
12
Rituximab
11
ibrutinib
10
fludarabine phosphate
9
acalabrutinib
7
obinutuzumab
6
Lenalidomide
6
Bendamustine Hydrochloride
6
venetoclax
5
pirtobrutinib
4
Vincristine
4
Mesna
4
Melphalan
4
Immunotherapy, Adoptive
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Chlorambucil
3
Bortezomib
3
Alemtuzumab
3
spebrutinib
2
navitoclax
2
idelalisib
2
Tacrolimus
2
Tablets
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
KW-2478
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Clarithromycin
×
Clear all
NCT01279252
2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2
Completed
71 enrolled